| __timestamp | Perrigo Company plc | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 675200000 | 305409000 |
| Thursday, January 1, 2015 | 771800000 | 377080000 |
| Friday, January 1, 2016 | 1205500000 | 432829000 |
| Sunday, January 1, 2017 | 1146500000 | 496079000 |
| Monday, January 1, 2018 | 1125800000 | 557616000 |
| Tuesday, January 1, 2019 | 1166100000 | 658498000 |
| Wednesday, January 1, 2020 | 1175500000 | 770456000 |
| Friday, January 1, 2021 | 1111400000 | 840100000 |
| Saturday, January 1, 2022 | 1210100000 | 944700000 |
| Sunday, January 1, 2023 | 1274600000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, understanding operational efficiency is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Vertex Pharmaceuticals Incorporated and Perrigo Company plc from 2014 to 2023. Over this period, Perrigo consistently outspent Vertex, with SG&A expenses peaking at approximately $1.27 billion in 2023, a 47% increase from 2014. In contrast, Vertex's expenses grew more modestly, reaching around $1.14 billion in 2023, marking a 272% rise from its 2014 figures. This stark difference highlights Perrigo's aggressive spending strategy compared to Vertex's more conservative approach. Such insights are invaluable for investors and stakeholders aiming to gauge the financial health and strategic priorities of these industry giants. As the pharmaceutical sector continues to evolve, monitoring these trends will be key to understanding future market dynamics.
Eli Lilly and Company and Vertex Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited Trends and Insights
Vertex Pharmaceuticals Incorporated or Ascendis Pharma A/S: Who Manages SG&A Costs Better?
Vertex Pharmaceuticals Incorporated and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Veracyte, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: SG&A Expense Trends
Comparing SG&A Expenses: Zoetis Inc. vs Perrigo Company plc Trends and Insights
Cost Management Insights: SG&A Expenses for GSK plc and Perrigo Company plc
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and Perrigo Company plc
Perrigo Company plc and Merus N.V.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Perrigo Company plc and Ligand Pharmaceuticals Incorporated